warnings
WARNINGS SECTION Mupirocin ointment is not for ophthalmic use.
MUPIROCIN
openFDA label record#
This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.
Verified complete openFDA source JSON
- Brand name
- MUPIROCIN
- Generic name
- MUPIROCIN
- Manufacturer
- DIRECT RX
- Product type
- HUMAN PRESCRIPTION DRUG
- SPL set ID
- f88eea1a-2ba1-48bf-96c8-d96d18752aaa
- SPL ID
- 4d7625bb-db93-7369-e063-6394a90a679f
- Version
- 4
- Effective date
- 2026-03-20
- Source export date
- 2026-09-28
- Source partition
- 4
- Source file
- https://download.open.fda.gov/drug/label/drug-label-0004-of-0014.json.zip
- Source object key
- raw/openfda/drug-label/2026-09-28/c7ca0b7091cdaeab3f27713a6eef00adcf8fe722383633ddce61531b4c840544/drug-label-0004-of-0014.json.zip
- Source manifest SHA-256
- cd2e66336a5cd2223fa3995098fdbdb84c6a7ee5c0a4addb236ccb22dd1e6887
- Import run
- 20260929T050834Z
- Imported at
- 2026-09-29 05:27:19
| Harmonized routes |
|---|
| TOPICAL |
Harmonized identifier links#
Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.
| Type | Scope | Identifier | Source field |
|---|---|---|---|
| application applno | ANDA | 065085 | derived:openfda.application_number |
| application number | ANDA065085 | openfda.application_number | |
| brand name | MUPIROCIN | openfda.brand_name | |
| generic name | MUPIROCIN | openfda.generic_name | |
| manufacturer name | DIRECT RX | openfda.manufacturer_name | |
| ndc | package | 61919-158-22 | openfda.package_ndc |
| ndc | product | 61919-158 | openfda.product_ndc |
| ndc11 | package | 61919015822 | derived:openfda.package_ndc |
| rxcui | 106346 | openfda.rxcui | |
| spl id | 4d7625bb-db93-7369-e063-6394a90a679f | id | |
| spl set id | f88eea1a-2ba1-48bf-96c8-d96d18752aaa | set_id | |
| unii | D0GX863OA5 | openfda.unii |
Warnings cross-check#
openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.
Adverse reactions cross-check#
openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.
adverse reactions
ADVERSE REACTIONS SECTION The following local adverse reactions have been reported in connection with the use of mupirocin ointment: burning, stinging, or pain in 1.5% of patients; itching in 1% of patients; rash, nausea, erythema, dry skin, tenderness, swelling, contact dermatitis, and increased exudate in less than 1% of patients.
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.